Scotland-based BioOutsource to Expand, Open U.S. Lab Facility in Massachusetts in 2015
Governor Patrick, Massachusetts officials meet with additional prospect companies during BIO International Convention
SAN DIEGO, CA, USA/GLASGOW, SCOTLAND – Wednesday, June 25, 2014 – Scotland-based BioOutsource joined with Massachusetts Governor Deval Patrick, Senate President Therese Murray, the Massachusetts Life Sciences Center and MassBio today to announce that the company will be expanding their U.S. presence, opening a new lab facility in Massachusetts in 2015. The company, a global leader in biologics contract testing and BioSimilar characterization for the biopharmaceutical industry, opened
their first U.S. office in 2013 in the life sciences hub of Cambridge, MA. The company plans to open the new laboratory facility in early 2015 to service their North American & Latin American clients. The new Laboratory Facility will support and strengthen the company’s BioSimilar and BioSafety service offerings.
Governor Patrick and other officials and industry leaders from Massachusetts will meet today with more than a dozen companies at the BIO International Convention in San Diego that are interested in learning more about locating or doing business in Massachusetts. The meetings will take place in the Massachusetts Pavilion on the show floor as part of the state’s “Global Connect” sessions.
“We welcome BioOutsource’s expansion in Massachusetts and look forward to their ongoing contributions to our thriving life sciences community,” said Governor Patrick.
"This announcement underscores the fact that Massachusetts is the place to be for expanding life sciences," Senate President Therese Murray (D-Plymouth) said. "BioOutsource's expansion is yet another tangible example of the success of the Life Sciences Initiative and the growth of the life science industry."
“Our innovation economy is fueling our recovery and is creating economic opportunity throughout the Commonwealth,” said Secretary of Housing and Economic Development Greg Bialecki. “We congratulate BioOutsource on its success and look forward to meeting with new prospective companies that are interested in doing business in the Commonwealth.”
BioOutsource announced that the last 12 months have been an exceptional growth year for the company. The Company has grown by more than 40%, with positive growth delivered across all business units.
“North America has always been an essential strategic element of our global expansion plans, exemplified by our US office and active membership of MassBio,” said BioOutsource CEO, Gerry McKay. “We are already a Global company and the time is right to extend our global client footprint with the addition of a new facility in the US. The new facility will benefit our existing and new clients, improving logistics and ensuring our technical experts are close by. We are delighted to announce our plans to open a new Laboratory Facility in Massachusetts and a further announcement will be made soon.”
“On behalf of the Center, I would like to extend our warmest congratulations to the team at BioOutsource as they develop their U.S. lab facility here in Massachusetts,” said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center, the agency charged with implementing Governor Patrick’s 10-year, $1 billion Life Sciences Initiative. “The Commonwealth of Massachusetts has one of the strongest concentrations of life sciences talent in the world, and I’m confident that BioOutsource will find the people, resources and clients that they need here to prosper.”
“We are excited to welcome Gerry and his team to Massachusetts, as the gateway into business in the U.S.,” said Robert K. Coughlin, President & CEO of MassBio, the life sciences trade association. “BioOutsource has already been and will continue to be great ambassadors to companies across the world who want to work in and with our researchers.”
About BioOutsource Ltd
BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of Biologics, Vaccines & Biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry’s increasingly preferred testing partner. We understand the importance of our service to support our client’s critical testing requirements and as a result, continually strive to provide a world class service globally. For more information visit www.biooutsource.com.
About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences. For more information, visit www.masslifesciences.com.
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 620 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.